Mass General Brigham researchers from the Gene Lay Institute of Immunology and Inflammation, along with researchers at ...
Explore groundbreaking research on biological aging, discover how cellular functions can be reprogrammed, and learn practical ...
November is a month of big changes in your life: choices, money, communication, relationships, career progression and the ...
A preclinical study reports that combining the serotonin-synthesis inhibitor telotristat ethyl with the mTOR inhibitor ...
A cyclone that powered up over unusually warm ocean waters hit part of India’s coastline that’s dense with billions of ...
A woman who sought medical care because her hair was slow to recover after chemotherapy-related hair loss. /Photo: Gemini ...
Global Single-Cell Omics Market size is expected to be worth around US$ 9.4 Billion by 2034 from US$ 2.1 Billion in 2024 ...
A Mayo Clinic study published in the Journal of Neuro-Oncology suggests that analyzing DNA in cerebrospinal fluid could provide another source of information when MRI cannot provide a clear brain ...
A prospective cohort study of 837 colorectal cancer patients linked distinct tumor blood-vessel features with colorectal ...
Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), an oncology-focused biopharmaceutical company and majority-owned subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") ...
Expert and company perspectives on the role of amivantamab in advancing first-line treatment “Patients with recurrent or metastatic head and neck cancer continue to face a poor prognosis, highlighting ...
Results support continued evaluation of the investigational RYBREVANT FASPRO regimen in the ongoing first-line Phase 3 study Data highlight the role of dual-targeting EGFR and MET, key drivers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results